Lite Strategy, Inc. (LITS) Stock Ticker
LITS right now
Market factors today
Unlock the full LITS picture
About Lite Strategy, Inc.
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
LITS stock facts
| Ticker symbol | LITS |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $49.0M |
| CEO | Justin J. File |
| Employees | 4 |
| Headquarters | San Diego, CA, US |
| IPO date | 2003-12-18 |
| Website | www.litestrategy.com |
What you can see for LITS on Tickr
Live LITS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LITS report.
Rankings
FAQ
What is the ticker symbol for Lite Strategy, Inc.?
The ticker symbol for Lite Strategy, Inc. is LITS, listed on the NASDAQ Capital Market.
What is LITS?
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San…